GI
NVRO

Gradient Investments’s NEVRO CORP. NVRO Stock Holding History

Gradient Investments’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed – – 1116
2018
Q3 		$0 Sell
1
-9,194
-100% -$575K ﹤0.01% 1083
2018
Q2 		$734K Buy
9,195
+2,555
+38% +$212K 0.04% 173
2018
Q1 		$575K Buy
6,640
+1,265
+24% +$102K 0.03% 174
2017
Q4 		$371K Buy
5,375
+1,116
+26% +$89.3K 0.02% 213
2017
Q3 		$387K Buy
4,259
+32
+0.8% +$2.74K 0.02% 178
2017
Q2 		$315K Buy
+4,227
New +$339K 0.02% 192

Other funds holding NVRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Gradient Investments's NVRO Position: Q4 2018 in Review

Gradient Investments sold out of NEVRO CORP. (NVRO) in Q4 2018, closing a stake of 1 share.

Gradient Investments first reported a position in NVRO in Q2 2017 and held it in 6 quarters. The position peaked at $734K in Q2 2018. 157 funds tracked by Wall St. Rank hold NVRO as of Q4 2018.

  • Gradient Investments reported no remaining NEVRO CORP. position as of Q4 2018 after selling out during the quarter.
  • Gradient Investments sold 1 NEVRO CORP. share in Q4 2018.
  • Gradient Investments first reported a position in NEVRO CORP. in Q2 2017 and held it in 6 quarters.
  • Gradient Investments's NEVRO CORP. position peaked at $734K in Q2 2018.
  • 157 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2018.

Based on Gradient Investments's 13F filing for Q4 2018, filed 18 Jan 2019.